Novartis Seeks Hidden Cures in Machine Learning, AI

July 11, 2018 Jessica Davis Senior Editor, Enterprise Apps

Novartis' Global Drug Development has completed the first phase of a digital transformation that has enabled it to better leverage one of its best assets -- data.

Previous Article
Most Health Organizations Can't Ensure Responsible AI Use
Most Health Organizations Can't Ensure Responsible AI Use

A report finds that most industry execs haven't yet committed to investing in AI data verification technology.

Next Article
Clear the Real-World Barriers to Better Data Utilization
Clear the Real-World Barriers to Better Data Utilization

Success with IT initiatives isn't just about creating data; it's about making good use of that data.